Top Quality Devices & Solutions for
At SomnoMed, we realize that no two patients are alike, which is why we pride ourselves on delivering a suite of SomnoDent oral devices with a wide array of options to treat your patients and successfully manage sleep apnea care.
SomnoMed, the leader in COAT (Continuous Open Airway Therapy)®, is passionate about providing solutions that lead to healthier patients, healthier practices, and healthier businesses. As a medical device manufacturer, we specialize in the development and distribution of premium oral appliances for the treatment of obstructive sleep apnea (OSA).
15+ clinical studies demonstrated the efficacy of SomnoDent oral devices in treating patients with mild-to-moderate OSA.
Access COAT bibliography and Clinical Research.
SomnoDent oral devices are made with the highest quality materials and manufactured under ISO 13485 standards with FDA 510(k) clearance. Learn More.
Growing family of SomnoDent oral devices not only achieve clinical efficacy and streamline care, but are designed to be inviting for patients to use night after night so patients can enjoy better days. Learn More.
Successfully managing sleep apnea patients in today’s changing healthcare environment is more challenging and costly than ever. It has become increasingly important to make diagnosing sleep conditions more efficient, make therapy easier for OSA patients to live with and make ongoing care more productive.
SomnoMed is proud to introduce Somnodent with compliance recorder – a definitive breakthrough merging oral device therapy with reliable compliance results you can depend on, only available through SomnoMed. SomnoDent with compliance recorder streamlines patient management while delivering easy access to essential data that empowers patients to drive their own compliance without the hassle of a CPAP.
“Our patients subjectively report that they use their SomnoDent devices at very high rates of compliance, but this is a way for physicians and dentists to reliably make sure that we are actually reaching those levels of compliance, because we know that the more compliant the patient is, the more effective the treatment.”
Dr. Jagdeep Bijwadia, SomnoMed Chief Medical Officer